[Treatment of hypercalcemia of myelomatous origin with intravenous diphosphonates].
S Charhon(Inserm), Meunier Pj, A. Valentin-Opran(Unknown), C Edouard(Laboratoire d'Hydrodynamique de l'École polytechnique), Chapuy Mc, S Rosini
PubMed
December 24, 1983
Cited by 6
Related Papers
RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 FOR TREATMENT OF OPEN TIBIAL FRACTURES
|Journal of Bone and Joint Surgery|2002|1.3k
Recombinant Human BMP-2 and Allograft Compared with Autogenous Bone Graft for Reconstruction of Diaphyseal Tibial Fractures with Cortical Defects
|Journal of Bone and Joint Surgery|2006|447
Clinical Evaluation of Recombinant Human Bone Morphogenetic Protein-2
|Clinical Orthopaedics and Related Research|2002|290